4.7 Review

Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines

期刊

PEDIATRICS
卷 134, 期 4, 页码 E1149-E1162

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2013-3189

关键词

cardio-facio-cutaneous syndrome; BRAF mutation; management guidelines; MEK1 mutation; MEK2 mutation; RASopathy

资金

  1. CFC International, Vestal, New York
  2. National Institutes of Health [R01-AR062165]
  3. National Institutes of Health (NIH)

向作者/读者索取更多资源

Cardio-facio-cutaneous syndrome (CFC) is one of the RASopathies that bears many clinical features in common with the other syndromes in this group, most notably Noonan syndrome and Costello syndrome. CFC is genetically heterogeneous and caused by gene mutations in the Ras/mitogen-activated protein kinase pathway. The major features of CFC include characteristic craniofacial dysmorphology, congenital heart disease, dermatologic abnormalities, growth retardation, and intellectual disability. It is essential that this condition be differentiated from other RASopathies, as a correct diagnosis is important for appropriate medical management and determining recurrence risk. Children and adults with CFC require multidisciplinary care from specialists, and the need for comprehensive management has been apparent to families and health care professionals caring for affected individuals. To address this need, CFC International, a nonprofit family support organization that provides a forum for information, support, and facilitation of research in basic medical and social issues affecting individuals with CFC, organized a consensus conference. Experts in multiple medical specialties provided clinical management guidelines for pediatricians and other care providers. These guidelines will assist in an accurate diagnosis of individuals with CFC, provide best practice recommendations, and facilitate long-term medical care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Biographical-Item Genetics & Heredity

IN MEMORIAM Mary Ella Mascia Pierpont: Geneticist, scientist, mentor, friend (1945-2020)

Elizabeth I. Pierpont, Susan A. Berry, Angela E. Lin, Jamie L. Lohr, Lisa A. Schimmenti, William B. Dobyns

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Pediatrics

The Impact of Erythropoietin on Short- and Long-Term Kidney-Related Outcomes in Neonates of Extremely Low Gestational Age. Results of a Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial

David J. Askenazi, Patrick J. Heagerty, Robert H. Schmicker, Patrick Brophy, Sandra E. Juul, Stuart L. Goldstein, Sangeeta Hingorani

Summary: ELGANs have high rates of in-hospital AKI and kidney-related problems at 22-26 months of cGA. Recombinant erythropoietin may protect ELGANs against long-term elevated SBP but does not appear to protect from AKI, low eGFR, albuminuria, or elevated DBP at 22-26 months of cGA.

JOURNAL OF PEDIATRICS (2021)

Article Genetics & Heredity

Impact of pediatric hypophosphatasia on behavioral health and quality of life

Elizabeth I. Pierpont, Jill H. Simmons, Katherine J. Spurlock, Ryan Shanley, Kyriakie M. Sarafoglou

Summary: Children with HPP are at increased risk for ADHD symptoms and other behavioral health challenges, which are often under-recognized in clinical practice. Approximately 67% of children with HPP exhibit clinically significant behavioral health challenges, such as sleep disturbance and symptoms of ADHD, which are associated with reduced physical and psychosocial quality of life. Despite age-typical development of adaptive skills in most children, emotional and behavioral challenges are linked to weaker adaptive function.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Genetics & Heredity

Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course

Nishitha R. Pillai, Dana Miller, Elizabeth I. Pierpont, Susan A. Berry, Anjali Aggarwal

Summary: Cobalamin J disease (CblJ) is an extremely rare genetic disorder characterized by metabolic disturbances and diverse clinical symptoms. Early detection and treatment can help patients remain asymptomatic with normal growth and neurodevelopmental function.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Endocrinology & Metabolism

Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy

Ashish O. Gupta, David R. Nascene, Ryan Shanley, Daniel L. Kenney-Jung, Julie B. Eisengart, Troy C. Lund, Paul J. Orchard, Elizabeth Pierpont

Summary: The study compared outcomes after hematopoietic cell transplantation (HCT) in pediatric patients with frontal lesions versus parieto-occipital lesions in childhood cerebral adrenoleukodystrophy (cALD). It found similar rates of transplant complications and disease advancement, but a higher prevalence of psychiatric problems in patients with frontal lesions, indicating a need for comprehensive care that addresses psychiatric needs.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

Article Clinical Neurology

Social behavior in RASopathies and idiopathic autism

Allison M. H. Foy, Rebekah L. Hudock, Ryan Shanley, Elizabeth Pierpont

Summary: This study compared different aspects of social behavior between children with RASopathies and idiopathic ASD. It found that children with RASopathies demonstrated more resilience in empathy compared to their overall social competence. The psychological factors that predicted social behavior were similar and different in these two groups. Stronger communication skills and fewer hyperactive-impulsive behaviors were associated with increased empathy and social competence in both groups. Greater emotional challenges were associated with lower social competence in children with RASopathies and stronger empathy in children with idiopathic ASD. Among children with both RASopathy and ASD, socially empathetic behaviors were observed more often. The findings highlight the distinct pattern of strengths and weaknesses in social behavior development among children with RASopathies and the importance of targeted intervention.

JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2022)

Article Genetics & Heredity

The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery

Maria Kontaridis, Amy E. Roberts, Lisa Schill, Lisa Schoyer, Beth Stronach, Gregor Andelfinger, Yoko Aoki, Marni E. Axelrad, Annette Bakker, Anton M. Bennett, Alberto Broniscer, Pau Castel, Caitlin A. Chang, Lukas Cyganek, Tirtha K. Das, Jeroen den Hertog, Emilia Galperin, Shruti Garg, Bruce D. Gelb, Kristiana Gordon, Tamar Green, Karen W. Gripp, Maxim Itkin, Maija Kiuru, Bruce R. Korf, Jeff R. Livingstone, Alejandro Lopez-Juarez, Pilar L. Magoulas, Sahar Mansour, Theresa Milner, Elisabeth Parker, Elizabeth Pierpont, Kevin Plouffe, Katherine A. Rauen, Suma P. Shankar, Shane B. Smith, David A. Stevenson, Marco Tartaglia, Richard Van, Morgan E. Wagner, Stephanie M. Ware, Martin Zenker

Summary: RASopathies are a group of genetic disorders caused by genes affecting the Ras/MAPK signaling pathway. Progress has been made in translating research findings to the clinic, with the use of pathway inhibitors for treatment. The seventh International RASopathies Symposium aimed to enhance new discoveries in the field and bring together stakeholders from various backgrounds.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Genetics & Heredity

Neurologic and neurodevelopmental complications in cardiofaciocutaneous syndrome are associated with genotype: A multinational cohort study

Elizabeth Pierpont, Daniel L. Kenney-Jung, Ryan Shanley, Abigail L. Zatkalik, Ashley E. Whitmarsh, Samuel J. Kroening, Amy E. Roberts, Martin Zenker

Summary: This study evaluated the neurological and neurodevelopmental features of patients with CFC syndrome and found that gene variants were associated with abnormal EEGs and neurodevelopmental impairments.

GENETICS IN MEDICINE (2022)

Review Biotechnology & Applied Microbiology

Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy

Ashish O. Gupta, Gerald Raymond, Elizabeth Pierpont, Stephan Kemp, R. Scott McIvor, Arpana Rayannavar, Bradley Miller, Troy C. Lund, Paul J. Orchard

Summary: Adrenoleukodystrophy (ALD) is a rare disorder that causes severe neuroinflammation and fatality. Historically, allogeneic hematopoietic stem cell transplantation (HSCT) has been the only therapeutic option to halt the progression of cerebral ALD. However, recent studies have explored lentiviral-based gene therapy as an alternative treatment.

EXPERT OPINION ON BIOLOGICAL THERAPY (2022)

Article Genetics & Heredity

Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype

Daniel. L. L. Kenney-Jung, Dante. J. J. Rogers, Samuel. J. J. Kroening, Abigail. L. L. Zatkalik, Ashley. E. E. Whitmarsh, Amy. E. E. Roberts, Martin Zenker, Maria Luigia Gambardella, Ilaria Contaldo, Chiara Leoni, Roberta Onesimo, Giuseppe Zampino, Marco Tartaglia, Domenica. I. I. Battaglia, Elizabeth. I. I. Pierpont

Summary: Gene variants affecting the RAS-MAPK pathway can cause CFCS, a multi-system disorder, with IESS being a serious complication. In this study, it was found that IESS occurred in 10% of CFCS patients, with most cases associated with BRAF variants. The onset of spasms occurred at a median age of 5.4 months and most patients required anti-seizure medication for treatment. Patients with a history of IESS had limited neurodevelopmental outcomes and were more likely to develop other types of epilepsy.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2022)

Review Endocrinology & Metabolism

Neurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening

Elizabeth I. Pierpont, Ashley R. Isaia, Erin McCoy, Sarah J. Brown, Ashish O. Gupta, Julie B. Eisengart

Summary: X-linked adrenoleukodystrophy (ALD) is a rare inherited neurological disorder that presents challenges for clinical management. This comprehensive review synthesizes current knowledge about the neurocognitive and mental health effects of ALD, providing context for improved patient care. The results highlight predictive factors and brain-behavior relationships associated with the diverse manifestations of ALD, while also identifying gaps for future research.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Editorial Material Clinical Neurology

A dimensional approach to neurodevelopmental differences in genetically well-defined populations: What's next?

Elizabeth I. Pierpont

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2023)

Article Genetics & Heredity

Epilepsy in cardiofaciocutaneous syndrome: Clinical burden and response to anti-seizure medication

Daniel L. Kenney-Jung, Josue E. Collazo-Lopez, Dante J. Rogers, Ryan Shanley, Abigail L. Zatkalik, Ashley E. Whitmarsh, Amy E. Roberts, Martin Zenker, Elizabeth I. Pierpont

Summary: This study analyzed the clinical characteristics of epilepsy and response to anti-seizure medications in patients with cardiofaciocutaneous syndrome. The results showed that many patients were unable to achieve adequate seizure control despite the use of multiple medications, suggesting a need for better treatment options.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Genetics & Heredity

The 8th International RASopathies Symposium: Expanding research and care practice through global collaboration and advocacy

Elizabeth I. Pierpont, Anton M. Bennett, Lisa Schoyer, Beth Stronach, April Anschutz, Sarah C. Borrie, Benjamin Briggs, Emma Burkitt-Wright, Pau Castel, Ion C. Cirstea, Fieke Draaisma, Michelle Ellis, Vanessa S. Fear, Megan N. Frone, Elisabetta Flex, Bruce D. Gelb, Tamar Green, Karen W. Gripp, Sattar Khoshkhoo, Mark W. Kieran, Karolin Kleemann, Bonita P. Klein-Tasman, Maria I. Kontaridis, Paul Kruszka, Chiara Leoni, Clifford Z. Liu, Nadia Merchant, Pilar L. Magoulas, Christopher Moertel, Carlos E. Prada, Katherine A. Rauen, Renee Roelofs, Rodrigue Rossignol, Christine Sevilla, Gigi Sevilla, Ryan Sheedy, Elliot Stieglitz, Daochun Sun, Dagmar Tiemens, Forest White, Ellen Wingbermuehle, Cordula Wolf, Martin Zenker, Gregor Andelfinger

Summary: Germline pathogenic variants in the RAS/mitogen-activated protein kinase (MAPK) signaling pathway are responsible for RASopathies, a group of genetically overlapping syndromes characterized by distinct facial features, short stature, cancer predisposition, and anomalies in major body systems. The 8th International RASopathies Symposium focused on global perspectives in clinical care and research, aiming to foster international collaborations and diverse patient cohorts for interventional trials.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Article Endocrinology & Metabolism

Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy

Rebecca E. Wiersma, Ashish O. Gupta, Troy C. Lund, Kyriakie Sarafoglou, Elizabeth Pierpont, Paul J. Orchard, Bradley S. Miller

Summary: Primary adrenal insufficiency (PAI) is often the initial manifestation of X-linked adrenoleukodystrophy (X-ALD), and early identification of X-ALD is critical for timely intervention. Plasma very long chain fatty acid testing should be performed in all boys with PAI to ensure the diagnosis of X-ALD.

JOURNAL OF THE ENDOCRINE SOCIETY (2022)

暂无数据